rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-1-24
|
pubmed:abstractText |
Recent clinical trials have suggested that intensive versus standard lipid-lowering therapy provides for additional benefit. Electron-beam computed tomography provides the opportunity to quantify the progression of coronary artery calcification (CAC) in serial measurements.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1524-4539
|
pubmed:author |
pubmed-author:AchenbachStephanS,
pubmed-author:BuddeThomasT,
pubmed-author:BuziashviliYuriY,
pubmed-author:ErbelRaimundR,
pubmed-author:FörsterAndreasA,
pubmed-author:FriedrichGuyG,
pubmed-author:HeneinMichaelM,
pubmed-author:KerkhoffGertG,
pubmed-author:KnollmannFriedrichF,
pubmed-author:KukharchukValeryV,
pubmed-author:LahiriAvijitA,
pubmed-author:LeischikRomanR,
pubmed-author:MoshageWernerW,
pubmed-author:SchartlMichaelM,
pubmed-author:SchmermundAxelA,
pubmed-author:SiffertWinfriedW,
pubmed-author:SinitsynValentinV,
pubmed-author:Steinhagen-ThiessenElisabethE,
pubmed-author:VogtAnjaA,
pubmed-author:WiedekingBurkhardB
|
pubmed:issnType |
Electronic
|
pubmed:day |
24
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
427-37
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16415377-Adult,
pubmed-meshheading:16415377-Aged,
pubmed-meshheading:16415377-Aged, 80 and over,
pubmed-meshheading:16415377-Anticholesteremic Agents,
pubmed-meshheading:16415377-Calcinosis,
pubmed-meshheading:16415377-Cholesterol, LDL,
pubmed-meshheading:16415377-Coronary Artery Disease,
pubmed-meshheading:16415377-Double-Blind Method,
pubmed-meshheading:16415377-Female,
pubmed-meshheading:16415377-Heptanoic Acids,
pubmed-meshheading:16415377-Humans,
pubmed-meshheading:16415377-Male,
pubmed-meshheading:16415377-Middle Aged,
pubmed-meshheading:16415377-Pyrroles,
pubmed-meshheading:16415377-Risk Factors,
pubmed-meshheading:16415377-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.
|
pubmed:affiliation |
Department of Cardiology, University Clinic Essen, Essen, Germany. A.Schmermund@ccb.de
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|